Top Markets
Coin of the day
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
주식 순위 #14760
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
주가
$2.35
시가총액
$394.12M
변동 (1일)
-1.07%
변동 (1년)
-64.75%
국가
TW
거래 Lumosa Therapeutics Co., Ltd. (6535)

카테고리

Lumosa Therapeutics Co., Ltd. (6535)의 주가 이력
최고 종가: $2.35 (2026-09-01 기준)

최저 종가: $1.29 (2015-07-01 기준)
Lumosa Therapeutics Co., Ltd.의 주가 이력 (2015 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -11.24%
2025 -7.99%
2024 206.71%
2023 67.55%
2022 -8.12%
2021 11.91%
2020 4.84%
2019 18.82%
2018 1.29%
2017 -28.93%
2016 -36.03%
2015 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$750.42 5.18%
CH